Leukocyte esterase strip test: matched for musculoskeletal infection society criteria

Eric H Tischler1, Priscilla K Cavanaugh1, Javad Parvizi1

  • 1The Rothman Institute at Thomas Jefferson Hospital, Thomas Jefferson University, Sheridan Building, 10th Floor, 125 South 9th Street, Philadelphia, PA 19107. E-mail address for J. Parvizi: parvj@aol.com.

Abstract

Insights

Leukocyte esterase in synovial fluid is an accurate marker for periprosthetic joint infection. This test shows high specificity and negative predictive value, aiding in diagnosing joint infections.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Biochemistry

Background:

  • Periprosthetic joint infection (PJI) diagnosis is challenging.
  • Leukocyte esterase in synovial fluid is a potential biomarker for PJI.
  • Previous studies lacked evaluation against current Musculoskeletal Infection Society (MSIS) criteria.

Purpose of the Study:

  • To determine the sensitivity and specificity of leukocyte esterase in synovial fluid for diagnosing PJI.
  • To evaluate leukocyte esterase against the established MSIS criteria for PJI.

Main Methods:

  • Prospective evaluation of leukocyte esterase in hip and knee synovial fluid aspirates (n=189).
  • Standard chemical test strips used for detection (graded negative, trace, +, ++).
  • Sensitivity, specificity, PPV, and NPV calculated for two positive thresholds (++ and +/++).

Main Results:

  • Leukocyte esterase test with +/++ threshold: Sensitivity 79.2%, Specificity 80.8%, PPV 61.8%, NPV 90.1%.
  • Leukocyte esterase test with ++ threshold: Sensitivity 66.0%, Specificity 97.1%, PPV 89.7%, NPV 88.0%.
  • The ++ threshold demonstrated high specificity (97.1%) and PPV (89.7%).

Conclusions:

  • Leukocyte esterase strip test shows high specificity and NPV when compared to MSIS criteria.
  • It is an accurate and effective marker for diagnosing periprosthetic joint infection.
  • Leukocyte esterase serves as a valuable adjunct diagnostic tool for PJI.